Patrick McGorry
Patrick McGorry "is Professor in the Department of Psychiatry at the University of Melbourne and Director of the Early Psychosis Prevention and Intervention Centre and the Youth Program, MH-SKY (Mental Health Services - Kids and Youth) in Melbourne." [1]
Patrick's biography notes that he "has contributed significantly to research in the area of early psychosis over the past 20 years playing a pivotal role in the development of service structures and treatments specifically targeting the needs of young people with emerging or first-episode psychosis. From 1987-1993 Pat was an Associate Investigator on the NHMRC funded Schizophrenia Research Unit at Royal Park Hospital and is the founding and current Executive Director of ORYGEN Youth Health and ORYGEN Research Centre. Pat has been successful in gaining numerous national and international grants from a variety of sources over many years and is currently the Chief Investigator on a NHMRC Program Grant and a Centre of Clinical Excellence Grant. He has published over 200 journal articles, chapters & books and has presented at many national and international conferences. As well as his contributions to the field of early psychosis, Professor McGorry has interests in the homeless, refugees and torture survivors, youth suicide, youth substance use and the treatment of emerging personality disorder."
"Pat is currently the President of the International Early Psychosis Association and an Executive Board Member, International Society for Psychological Treatments in Schizophrenia & Related Psychosis. He is also a member of the International Society for Traumatic Stress Studies, the International Association for Cognitive Psychotherapy, the Constitution Committee of the World Federation of Societies of Biological Psychiatry, the Organising Committee of the Section on Schizophrenia of the World Psychiatric Association and also a member of the Founding Board of Directors of the Schizophrenia International Research Society (SIRS). He has been awarded many prizes for his significant contributions to education, research and clinical psychiatry." [2]
Grant Making
From 2002 to 2005 Patrick McGorry was a committee member of the Pfizer Neuroscience Research Grants - Australian Physicians Independent Committee which was established in 2002 to support and advance basic and clinical research in the fields of neuroscience including psychiatry, pain medicine, neurology, and associated areas. [1] Patrick McGorry has also held positions on the advisory boards for Janssen-Cilag, Bristol-Myers Squibb, Lundbeck, Sanofi-Synthelabo and AstraZeneca.[2]
Grants Received
Patrick McGorry has received funding from the Colonial Foundation, Janssen-Cilag, National Health and Medical Research Council, Pfizer Inc. and the Australian Rotary Health Research Fund [3] Patrick McGorry received funding for research also from Eli Lilly, Novartis and AstraZeneca.[4]
External links
- Richard Gosden, "CHAPTER 10, Early Psychosis: Preventive Medicine, Scientific Assault on Mystical Tendencies, or an Extension of Social Control?", University of Wollongong (Australia), PhD, 2000.
References
- ↑ "Internet Archive - NSR Grants 2005", Internet Archive accessed August 21, 2011.
- ↑ "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders", Page 25 of document, accessed August 24, 2011.
- ↑ "Find an Expert - Profiling the University of Melbourne's Researchers", Website accessed August 21, 2011.
- ↑ "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders", Page 25 of document, accessed August 24, 2011.
